Welcome to LookChem.com Sign In|Join Free
  • or
pyridin-3-ylmethyl all-Z-4,7,10,13,16,19-docosahexaeneoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

92510-91-3

Post Buying Request

92510-91-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

92510-91-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 92510-91-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,5,1 and 0 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 92510-91:
(7*9)+(6*2)+(5*5)+(4*1)+(3*0)+(2*9)+(1*1)=123
123 % 10 = 3
So 92510-91-3 is a valid CAS Registry Number.

92510-91-3Downstream Products

92510-91-3Relevant academic research and scientific papers

Improved LC-MS method for the determination of fatty acids in red blood cells by LC-orbitrap MS

Li, Xingnan,Franke, Adrian A.

, p. 3192 - 3198 (2011/11/04)

We report a new method for fast and sensitive analyses of biologically relevant fatty acids (FAs) in red blood cells (RBC) by liquid chromatography mass spectrometry (LC-MS). A new chemical derivatization approach was developed forming picolylamides from FAs in a quantitative reaction. Fourteen derivatized FA standards, including saturated and unsaturated FAs from C14 to C22, were efficiently separated within 15 min. In addition, the use of a recently introduced benchtop orbitrap mass spectrometer under positive electrospray ionization (ESI) full scan mode showed a 2-10-fold improvement in sensitivity compared with a conventional tandem MS method, with a limit of detection in the low femtomole range for saturated and unsaturated FAs. The developed method was applied to determine FA concentrations in RBC with intra- and interday coefficients of variation below 10%.

DHA Esters and Use Thereof In Treatment and Prevention of Cardiovascular Disease

-

Page/Page column 4, (2009/12/27)

The present invention relates to a docosahexaenoic acid ester with an alcohol chosen among the group-B vitamins or provitamins, advantageously comprised by: nicotinyl alcohol of the following formula (I), panthenol of the following formula (II), and inositol of the following formula (III) or with isosorbide of the following formula (IV) or isosorbide mononitrate of the following formula (V). It also relates to a method of preparation of same, a pharmaceutical composition comprising same and the use of same in the treatment or prevention of cardiovascular disease, in particular auricular fibrillation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 92510-91-3